Global Hydraulic Press Machine Market to Witness 4.8% CAGR during 2017 - 2023     |   Global Auto-Injectors Market to Witness 18.6% CAGR during 2017 – 2023     |    Global Ammonium Phosphate Market to Witness 3.6% CAGR During 2016 – 2022

Toll Free (US/Canada): 1-888-778-7886

INT'L: 1-347-960-6455

enquiry@psmarketresearch.com

P&S Market Research - A market research firm

Pharmaceuticals Industry Insights

 

Pharmaceuticals

The players in the pharmaceutical industry include large pharmaceutical manufacturers, speciality pharmaceutical manufacturers, contract research organization and distributors. The pharmaceutical sector is experiencing some positive trends such as improving early-stage product pipelines, mainly for cancer and diabetes drugs and a plethora of new products being introduced. The industry is driven by various key drivers such as ageing population, rise in chronic diseases and rising demand for pharma products in the emerging economies. Apart from various favourable trends, the industry is also faced with various bottlenecks such as intense competition among the generic drug makers, pricing pressures and a comparatively declining level of research and development activity. In order to overcome these bottlenecks, the players in the market need to refocus on their R&D activities and value chain costs.

Research Reports

Publishing

Price

Anal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Anal Cancer Therapeutics Pipeline Analysis report
  • Anal cancer therapeutic pipeline analysis is expected to increase owing to increasing incidence globally, majorly in older adults. Major factors driving towards the pipeline growth for anal cancer include growing rate of sexually transmitted diseases and aging population. Additionally, increasing awareness regarding health issues among people is another major factor fueling the pipeline growth for anal cancer. According to American Cancer Society, the ...Continue Reading

Upcoming Report

$3250

Chronic Myelocytic Leukemia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Chronic Myelocytic Leukemia Therapeutics Pipeline Analysis report
  • Chronic myelocytic leukemia therapeutic pipeline analysis is expected to grow rapidly due to the increasing prevalence of the disease, globally. Some of the main factors driving the pipeline analysis for chronic myelocytic leukemia include increasing aging population and rising prevalence of chronic myelocytic leukemia, and increasing health awareness. Chronic myelocytic leukemia have high incidence rate in men and is the second most common type ...Continue Reading

Upcoming Report

$3250

Ulcerative Colitis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Ulcerative Colitis Pipeline Analysis report
  • Ulcerative colitis is a chronic inflammatory disease, which basically affects colonic mucosa. The main identified symptoms of the disease are bloody diarrhea, abdominal cramps and fatigue. Some of the other symptoms include, fever, vomiting, anorexia, abdominal distension and bloating. The leading cause of ulcerative colitis is the imbalance in regulation of gastrointestinal immune system. According to the International Society for Pharmacoeconomic and Outcomes Research journal named as value in health, the prevalence of ...Continue Reading

April 2017

$2500

Bipolar Disorder Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Bipolar Disorder Therapeutics Pipeline Analysis report
  • Bipolar disorder therapeutic pipeline analysis is expected to increase on account of increasing instances of issues related to depression and other mental disorders, across the world. Major factors driving the pipeline analysis for bipolar disorder are obesity, stress, incidence of nervous system trauma, depression, low market penetration of medicines as very small number of companies are making an analog. In addition, increasing awareness regarding ...Continue Reading

Upcoming Report

$3250

Diabetic Gastroparesis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Gastroparesis Therapeutics Pipeline Analysis report
  • Diabetic Gastroparesis therapeutic pipeline analysis is expected to grow as observed by the current situation of increasing prevalence of diabetes, globally. Major factors driving the pipeline analysis for diabetic gastroparesis include obesity, incidence of diabetes mellitus, stress conditions and gastroesophageal reflux disease. As there are very limited number of companies are making an analog for treatment and increasing awareness about health issues are ...Continue Reading

Upcoming Report

$3250

Hemophilia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hemophilia Therapeutics Pipeline Analysis report
  • The hemophilia therapeutics pipeline is expected to grow in future due to rise in prevalence of genetic variation. Hemophilia which is symptomatized by excessive bleeding in brains, joints, nose and mouth. Some of the drivers for the growth of the hemophilia therapeutics pipeline include increasing incidence of hemophilia, less number of drugs present for treatment of hemophilia. ...Continue Reading

Upcoming Report

$3250

Myocardial Infarction Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Myocardial Infarction Therapeutics Pipeline Analysis report
  • The myocardial infarction therapeutics pipeline is expected to increase in future due to rise in prevalence of myocardial infarction. Myocardial infarction is also commonly known as heart attack which is symptomatized by decrease in blood supply to the heart muscle due to coronary artery disease. According to American Heart Association, the mortality rate due to cardiovascular disease is higher than other disease. According to British Heart Foundation, in 2015 ...Continue Reading

Upcoming Report

$3250

Neuroblastoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Neuroblastoma Therapeutics Pipeline Analysis report
  • The neuroblastoma therapeutics pipeline is expected to witness considerable growth in the future due to high prevalence of tumour in children. According to the American Cancer Society, around 7.0% of total cancer cases occurred in the age group of 0 to 14, observed as neuroblastoma, with most of the cases being reported at an age of 2 to 3 years. There are various immunotherapies and targeted drug therapies that are being developed for treatment of  ...Continue Reading

Upcoming Report

$3250

Pulmonary Arterial Hypertension Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Pulmonary Arterial Hypertension Therapeutics Pipeline Analysis report
  • The pulmonary arterial hypertension therapeutics pipeline is expected to increase in over next few years due to increasing prevalence of pulmonary arterial hypertension. Pulmonary arterial hypertension causes difficulty in blood supply to the lungs due to stiffness, tightening or blockage of a pulmonary artery. Some of the drivers for the growth of pulmonary arterial hypertension therapeutics pipeline include increasing incidence of vascular disease, change in ...Continue Reading

Upcoming Report

$3250

Diabetic Retinopathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Diabetic Retinopathy Therapeutics Pipeline Analysis report
  • Diabetic retinopathy therapeutic pipeline analysis is projected to grow as perceived by the current situation of increasing prevalence of diabetes, globally. Some of the main factors driving the pipeline analysis for diabetic retinopathy include obesity, incidence of diabetes mellitus, stress conditions and increasing prevalence of diabetic retinopathy, low market penetration since a limited number of companies are making an analog and increasing ...Continue Reading

Upcoming Report

$3250

Growth Hormone Deficiency Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Growth Hormone Deficiency Therapeutics Pipeline Analysis report
  • Growth hormone deficiency (GHD) therapeutics pipeline is predicted to increase in future mainly due to the increasing prevalence of the disease, globally. The major factors driving the pipeline of growth hormone deficiency include, increasing prevalence of pituitary dysfunction, low market penetration as very limited number of companies are making an analog of growth hormone. The rising affordability of the drugs and increasing geriatric population also serve ...Continue Reading

Upcoming Report

$3250

Hodgkin’s Lymphoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Hodgkins Lymphoma Therapeutics Pipeline Analysis report
  • The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development ...Continue Reading

Upcoming Report

$3250

Multiple Myeloma (MM) Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Multiple Myeloma Therapeutics Pipeline Analysis report
  • The multiple myeloma therapeutics pipeline is expected to witness considerable growth in the coming year due to high prevalence of the disease. The growth of multiple myeloma therapeutics pipeline is assisted by targeted therapy and new effective treatment. Also, increased awareness among the population about the various cancer treatments has further fueled the growth of the therapeutics pipeline. Increasing healthcare expenditure and ...Continue Reading

Upcoming Report

$3250

Thyroid Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Thyroid Cancer Therapeutics Pipeline Analysis report
  • The thyroid cancer therapeutics pipeline is expected to witness considerable growth due to increase in the demand for the targeted drug formulation for the treatment of cancer. Though less number of drugs are available for thyroid cancer treatment, an increasing awareness regarding cancer treatment and high demand for safe and effective medications are driving the therapeutics pipeline. ...Continue Reading

Upcoming Report

$3250

Atopic Dermatitis Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Atopic Dermatitis Pipeline Analysis report
  • The pipeline for atopic dermatitis therapeutic is expected to witness significant growth in the future due to rising prevalence of the disease and food allergies, which is expected to impact around 20.0% of the global population in the developed countries, according to a research done by Nutrition and Health Department, Nestle Research Centre, in 2015. Many generic drugs are already being given, but with the introduction of biologics, particularly ...Continue Reading

Upcoming Report

$3250

Acute Respiratory Distress Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Acute Respiratory Distress Syndrome Therapeutics Pipeline Analysis report
  • The acute respiratory distress syndrome therapeutics pipeline is expected to witness nominal growth in the coming year due to the slow research and development activities of the pipeline drugs. Some of the factors driving the growth of the pipeline include approval of new therapies that include but are not limited to, tissue factor antagonists, cluster of differentiation modulators, p38 kinase inhibitors and DNA polymerase inhibitors. Also, increasing awareness ...Continue Reading

Upcoming Report

$3250

Crohn’s Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Crohns Disease Therapeutics Pipeline Analysis report
  • The Crohn’s disease therapeutics pipeline is expected to witness extensive growth in the coming year due to emerging biosimilars and novel treatments. In addition, increasing number of pipeline drugs, rising demand for better medications, high prevalence of Crohn’s disease, involvement of the regulatory bodies for funding and designation and increase in the government agencies for the healthcare expenditure act as the major drivers for the Crohn’s disease therapeutics. ...Continue Reading

Upcoming Report

$3250

Cytomegalovirus (CMV) Infection Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Cytomegalovirus Infection Therapeutics Pipeline Analysis report
  • The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process ...Continue Reading

Upcoming Report

$3250

Fallopian Tube Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Fallopian Tube Cancer Therapeutics Pipeline Analysis report
  • The fallopian tube cancer therapeutics pipeline is a major focus for the pharmaceutical companies and researchers since it is one of the most debilitating women’s disease. The invention of novel drug delivery and the targeted therapy is expected to drive the pipeline growth for fallopian tube cancer. Increasing awareness regarding cancer treatment, advancement in technologies, high demand for safe and effective medications and high prevalence of ...Continue Reading

Upcoming Report

$3250

Gallbladder Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Gallbladder Cancer Therapeutics Pipeline Analysis report
  • Gallbladder cancer therapeutics pipeline is expected to witness increased growth in the future since very less number of drugs are available in the pipeline for the treatment of gallbladder cancer. There is an increase in awareness towards cancer treatments, increasing demand for safe and effective medicines, rising healthcare expenditure and technological advancements are supporting the growth of the gallbladder therapeutics pipeline. ...Continue Reading

Upcoming Report

$3250

Kaposi sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Kaposi sarcoma Therapeutics Pipeline Analysis report
  • The kaposi sarcoma therapeutics pipeline is expected to grow rapidly as the disease also has the risk of the patient being infected with Acquired Immune Deficiency Syndrome (AIDS). AIDS is the most common risk factors of kaposi sarcoma, which develops in people who are infected with HIV. The Kaposi sarcoma therapeutics pipeline is expected to generate large revenue due to increasing awareness regarding cancer treatments, high demand for safe and ...Continue Reading

Upcoming Report

$3250

Venous Thromboembolism Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Venous Thromboembolism Therapeutics Pipeline Analysis report
  • The venous thromboembolism therapeutics pipeline is expected to witness considerable growth in the coming year due to the development of novel oral anticoagulants as a reasonable and established treatment option. The regulatory bodies are supporting the drug development process through different types of designations and funding. The pipeline is being driven by different factors such as increasing awareness regarding the venous thromboembolism ...Continue Reading

Upcoming Report

$3250

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Phosphoinositide 3 Kinase Inhibitor Pipeline Analysis report
  • Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that play a vital role in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules in PI3K/AKT/mTOR signaling pathway by sending chemical messengers from cell surface to cytoplasm. These signals activate multiple effector kinase pathways, including protein kinase B, bruton's tyrosine kinase and protein kinase C pathway, which result in survival and growth of normal cells. Recent cancer studies have shown that ...Continue Reading

April 2017

$2500

IgA Nephropathy Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research IgA Nephropathy Pipeline Analysis report
  • Immunoglobulin A Nephropathy, also known as IgA nephropathy (IgAN) or Berger’s disease, is a kidney disorder that arises when IgA builds up in the kidneys, resulting in inflammation which causes damage to kidney tissues. IgA is an immunoglobulin A antibody produced by immune system for body protection from foreign substances such as viruses or bacteria. Production of IgA deposits damages the glomeruli and this results in blood and protein in urine. This progresses over time and eventually results in end stage renal ...Continue Reading

April 2017

$1850

Sjögren’s Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments

  • P&S Market Research Sjogrens Syndrome Therapeutics Pipeline Analysis report
  • Sjögren’s syndrome is a chronic, autoimmune disease identified by lymphocytic infiltration of exocrine glands and epithelia, which leads to sicca symptoms of dry eyes and dry mouth, and objective evidence of keratoconjunctivitis sicca and xerostomia. Sjogren’s syndrome can be present as primary Sjogren’s syndrome, as itself, or as secondary Sogren’s syndrome, in association with underlying immune conditions. Clinical presentation can vary considerably from relatively mild sicca symptoms, fatig ...Continue Reading

April 2017

$2500

Global Testicular Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Testicular Cancer Therapeutics Market report
  • Global testicular cancer therapeutics market is growing with the increasing prevalence of testicular cancer. The market is expected to witness moderate growth, since there are already more than 15 drugs that exist in the market for the treatment of testicular cancer. Increasing prevalence of cancer and rising demand for the medications with better efficacy and less side effects can be attributed as an opportunity for oncology. The regulatory bodies such as ...Continue Reading

Upcoming Report

$5100

Global Acute Lymphoblastic Leukemia (ALL) Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Acute Lymphoblastic Leukemia Therapeutics Market report
  • The global acute lymphoblastic leukemia therapeutics market is expected to witness considerable growth in the coming year since new drug formulations are proving to be the most effective treatment for cancer. An increasing awareness regarding cancer treatment, various technological advancements, high demand for safe and effective medications and high prevalence of cancer, are driving the growth of the global acute lymphoblastic leukemia therapeutics ...Continue Reading

Upcoming Report

$5100

Global Acute Myeloid Leukemia (AML) Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Acute Myeloid Leukemia Therapeutics Market report
  • The global acute myeloid leukemia therapeutics market is expected to witness notable growth, in the coming year due to increase in the new innovative and targeted drug delivery system. Various factors such as rising awareness regarding cancer treatments, increasing demand for safe and successful medications, rising incidence of cancer and technological advancements have been driving the growth of the global acute myeloid leukemia therapeutics ...Continue Reading

Upcoming Report

$5100

Global Chronic Lymphocytic Leukemia (CLL) Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Chronic Lymphocytic Leukemia Therapeutics Market report
  • The global chronic lymphocytic leukemia therapeutics market is expected to create more opportunities in oncology due to promising pipeline and positive clinical data of drug candidates. The existing drugs for the treatment of chronic lymphocytic leukemia is the be most effective treatment. The American Cancer Society, and other regulatory bodies are supporting the chronic lymphocytic leukemia therapeutics market by providing funding and grants. ...Continue Reading

Upcoming Report

$5100

Global Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Benign Prostatic Hyperplasia Therapeutics Market report
  • The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding ...Continue Reading

Upcoming Report

$5100

Global Endometrial Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Endometrial Cancer Treatment Market report
  • Global endometrial cancer therapeutics market is expected to witness significant growth as there are less number of approved drugs for treatment of endometrial cancer, leading to an increased opportunity for the drug manufacturers. High prevalence of cancer and rising demand for safe and effective medications can be attributed as the major drivers of this market. The regulatory bodies such as USFDA and EMA are supporting the growth of the global ...Continue Reading

Upcoming Report

$5100

Global Esophageal Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Esophageal Cancer Therapeutics Market report
  • Global endometrial cancer therapeutics market is expected to witness significant growth as there are less number of approved drugs for treatment of endometrial cancer, leading to an increased opportunity for the drug manufacturers. High prevalence of cancer and rising demand for safe and effective medications can be attributed as the major drivers of this market. The regulatory bodies such as USFDA and EMA are supporting the growth of the global ...Continue Reading

Upcoming Report

$5100

Global Neuroendocrine Carcinoma Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Neuroendocrine Carcinoma Therapeutics Market report
  • Global neuroendocrine carcinoma therapeutics market is witnessing significant growth due to large number of marketed drugs and Phase III drugs. Neuroendocrine carcinoma is a tumor that begins in neuroendocrine cells and can spread, or metastasize, to other parts of the body. It starts in the hormone producing cells of the body’s neuroendocrine system. Neuroendocrine tumors can begin in many organs including, lungs, brain and ...Continue Reading

Upcoming Report

$5100

Global Oropharyngeal Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Oropharyngeal Cancer Therapeutics Market report
  • The global oropharyngeal cancer therapeutics market is expected to have significant growth since the pipeline for oropharyngeal cancer is growing rapidly. Also, there are no specific drugs available for the treatment of oropharyngeal cancer providing increased opportunities for the major key players. ...Continue Reading

Upcoming Report

$5100

Global Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Pancreatic Cancer Therapeutics Market report
  • The global pancreatic cancer therapeutics market holds numerous opportunities for the key players, as pancreatic cancer is a highly challenging disease among all types of cancer, which has no specific treatment available for it, as of now. Also, growing incidence of cancer and technological advancements are supporting the growth of the global pancreatic cancer therapeutics market growth. ...Continue Reading

Upcoming Report

$5100

Global Bile Duct Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023

  • P&S Market Research Bile Duct Cancer Therapeutics Market report
  • The global bile duct cancer therapeutics market is expected to witness noticeable growth, in the near future, owing to increasing awareness about cancer and advancements in technologies for cancer treatment. Also, the increasing incidence of cancer is driving the bile duct cancer therapeutics market, globally. ...Continue Reading

Upcoming Report

$5100

Alzheimer’s Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Alzheimers Disease Pipeline Analysis report
  • Alzheimer’s disease is a progressive brain disorder that gradually destroys thinking skills and memory, and ultimately the capability to carry out the basic tasks. Alzheimer’s disease is presently ranked as the third leading cause of death in the aging population, after heart disease and cancer. Alzheimer’s is the most common form of dementia among elder adults. Dementia is the loss of behavioral abilities and cognitive functioning which results in interference with a person’s daily life and activi ...Continue Reading

March 2017

$4000

Estrogen Receptor-Positive Breast Cancer Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Estrogen Receptor Positive Breast Cancer Pipeline Analysis report
  • Estrogen Receptor-Positive (ER+) breast cancer is the most common type of breast cancer diagnosed and it refers to the cancer cells that have receptors on their surface to bind with estrogen. Breast cancer is said to be estrogen receptor-positive (ER+), if it contains estrogen that receives signals from estrogen to promote cell growth. Breast cancer is a syndrome that affects breast tissues and cells in the breast grow in an uncontrollable manner forming ...Continue Reading

March 2017

$2500

Rhinovirus Infection Therapeutics – Clinical Pipeline Development Analysis

  • P&S Market Research Rhinovirus Infection Therapeutics Pipeline Analysis report
  • Rhinovirus is a small, non-enveloped, icosahedral virus having size of around 27 nm diameter. It contains one positive-strand RNA and belongs to Picornavirus family. Discovered in 1956, rhinovirus has over 100 antigenically distinct serotypes such as RhV A, RhV B groups, and RhV A2 and RhV C subclasses, based on their sequence similarity and cell entry receptors. Human rhinovirus is a positive-sense RNA virus of 7.2 kb single strand, having ...Continue Reading

Upcoming Report

$5100

Serine/Threonine-Protein Kinase Inhibitors Pipeline Analysis, 2017

  • P&S Market Research Serine Threonine Protein Kinase Inhibitors Pipeline Analysis report
  • Serine/threonine-protein kinases (EC 2.7.11.1) are enzyme or protein that has hydroxyl (OH) group in the side chain. Phosphorylation in serine or threonine residues may cause changes in the function of the target protein. Those drugs/ligands that inhibit phosphorylating activity of these kinases are called serine/threonine protein kinases inhibitors. Serine/threonine kinase receptors are a family of transmembrane receptors containing intracellular ...Continue Reading

Upcoming Report

$3250

Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis, 2017

  • P&S Market Research Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis report
  • Vasomotor symptoms occur when a woman reach the state of menopause and ovaries stop producing eggs, and there is a reduction in secretion of hormones such as estrogen and progesterone. It usually occurs naturally, most often between age of 45 years to 51 years. The women feel perimenopausal transition that generally occurs prior to cessation of menstruation. During perimenopausal transition, the menstruation cycle becomes ...Continue Reading

Upcoming Report

$3250

Janus Kinase (JAK) Inhibitors Pipeline Analysis, 2017

  • P&S Market Research Janus Kinase Inhibitors Pipeline Analysis report
  • Janus kinase (JAK) inhibitors block Janus kinase activator enzymes and interrupt signaling pathway. It plays an important role in host defense, oncology, autoimmunity and hematological cancers, which makes them an important target for therapeutics. Many signal transduction pathways are done by JAK activity for the normal signaling. The abnormal aberration in JAKs activity can lead to diseased state. For instance, over activation of JAK can lead to ...Continue Reading

Upcoming Report

$3250

Lysosomal Storage Disorders Pipeline Analysis, 2017

  • P&S Market Research Lysosomal Storage Disorders Pipeline Analysis report
  • The deficiency of lysosomal enzymes cause lysosomal storage disorders (LSDs). It occurs due to mutations of genes that encode proteins, enzyme and related cofactors. There are approximately 50 types of LSDs. LSDs such as Gaucher disease, Fabry disease, Niemann-Pick disease, Pompe disease, Hunter syndrome, Mucopolysaccharidosis type III, Metachromatic leukodystrophy, Tay-Sachs disease and Batten disease affect different parts of body ...Continue Reading

Upcoming Report

$3250

Fungal Infections Pipeline Analysis, 2017

  • P&S Market Research Fungal Infections Pipeline Analysis report
  • Fungal Infection is a major cause of morbidity worldwide. Fungal Infections are caused by different fungi found in environment. Although, some fungi are not dangerous at all but few types of fungi are harmful to health. It involves the invasion of tissue such as skin and lung by specific type of fungi. According to Centers for Disease Control and Prevention (CDC), a public health institute in the U.S., approximately 1.5 million different species of fungi are present on ...Continue Reading

Upcoming Report

$3250

Hepcidin antagonist, Pipeline Analysis, 2017

  • P&S Market Research Hepcidin antagonist Pipeline Analysis report
  • Hepcidin is a small peptide which acts as iron regulatory hormone. The name ‘hepcidin’ is taken from the place of synthesis in hepatocytes (hep), whereas cidin denotes its antimicrobial activity. Liver is the key organ that secrete hepcidin and regulates iron hormone. Hepcidin was initially observed in human urine sample and in human blood ultrafiltrate as a small bactericidal peptide (defensin and cathelicidin) and now it is known as liver–expressed ...Continue Reading

Upcoming Report

$3250

Interstitial Cystitis (IC) Disease Pipeline Analysis

  • P&S Market Research Interstitial Cystitis Disease Pipeline Analysis report
  • Interstitial Cystitis (IC) is a painful bladder syndrome in which inflamed and irritated bladder cause recurring discomfort or pain. The symptoms of IC include an urgent or frequent need to urinate and pain during bladder filling. Women are more prone to develop this condition. Pain may be mild or so severe as to be debilitating and it can vary from day to day. IC is categorized into non-ulcerative and ulcerative. Non-ulcerative IC is the most common condition found in ...Continue Reading

Upcoming Report

$5100

Beta-Secretase (BACE) Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Beta Secretase Inhibitors Pipeline Analysis report
  • BACE is a cleaving enzyme of aspartyl protease with beta-secretase activity. It acts as a precursor of beta-amyloid (Aβ) protein. In Alzheimer’s disease, the Aβ protein fragments get accumulated in plaques in the brain. BACE initiates Aβ production by cleaving amyloid precursor protein (APP) to generate APPβ and C99, which is critical for the subsequent cleavage of C99 by gamma-secretase to release Aβ1-40 and Aβ1-42. Inhibition of BACE enzyme disrupts the ...Continue Reading

February 2017

$1850

AKT/Protein Kinase B (PKB) Inhibitors Pipeline Analysis, 2017

  • P&S Market Research AKT Protein Kinase B Inhibitors Pipeline Analysis report
  • AKT, also known as Protein Kinase B (PKB), is overexpressed or activated in large number of human cancers, including breast, lung, gastric, ovary and pancreas. AKT inhibitor inhibits the activated form of AKT that leads to normal functioning of AKT kinases. AKT has three isoforms; AKT1, AKT2 and AKT3, which play an important role in regulation of diverse cellular functions such as metabolism, motility, cell survival, cell-cycle progression and transcription. ...Continue Reading

Upcoming Report

$3250

Global BET Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research BET Inhibitors Pipeline Analysis report
  • Bromodomain and extra-terminal (BET) inhibitors are small molecule inhibitors including bromodomain 2 (BRD2), bromodomain 3 (BRD3), bromodomain 4 (BRD4) and bromodomain testis (BRDT), which have anti-proliferating properties. These targets of inhibitors are supposed to bind with myc gene, which is a most desired target for cancer therapeutics. BET inhibitors are first-in-class targeted therapies that directly target bromodomain proteins to deliver a new ...Continue Reading

February 2017

$2500

Global Idiopathic Pulmonary Fibrosis (IPF) Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research Idiopathic Pulmonary Fibrosis Therapeutics Market report
  • Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs becomes stiff and dense over time. The scar tissue formation is known as fibrosis. As the fibrosis progresses and tissue become darker, lungs can't properly move oxygen into the bloodstream, which result in oxygen deficiency in brain and other organs. ...Continue Reading

February 2017

$2500

Global T-Cell Immunotherapy Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • P&S Market Research T Cell Immunotherapy Pipeline Analysis report
  • T-cell immunotherapy mainly consists of T-cell receptor (TCR), Tumor-infiltrating lymphocytes (TILs) and Chimeric antigen receptors (CAR) T-cell therapy. TCR is a complex integral membrane protein that activates T-cells in response to an antigen. ...Continue Reading

January 2017

$4000

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

  • P&S Market Research PD1 and PDL1 Inhibitors Market report
  • Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) inhibitors are the therapeutic candidates or drugs, popularly known as checkpoint inhibitors, used most commonly for the treatment of cancer and other malignancies. Programmed death 1 (PD-1) is found on the surface of cancer cells and it is used by tumor cells to evade the immune system. PD-1 inhibitors  ...Continue Reading

January 2017

$6500

Global Protein A Resin Market Size, Share, Development, Growth and Demand Forecast to 2025

  • P&S Market Research Protein A Resin Market report
  • The global protein A resin market is expected to witness considerable growth during the forecast period due to the increasing research and development activities and increasing prevalence of chronic diseases. High traction for monoclonal antibodies in biopharmaceutical industry is supporting the growth of the global market. The increasing demand for monoclonal antibodies has fueled the need for high capacity commercial scale purification of monoclonal antibodies. Protein A resins are designed for the simple and rapid puri ...Continue Reading

Upcoming Report

$5100

Global Antibody Drug Conjugates (ADCs) Therapeutics Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research ADCs Therapeutics Market report
  • The global antibody drug conjugates (ADCs) therapeutics market is expected to witness significant growth due to current unmet medical need of some chronic diseases such as cancer and immunological diseases, increasing prevalence of such diseases, advancement in technologies and high demand for safe and effective medication. The regulatory bodies are supporting the ADCs market by providing designations and funding for speeding up the drug ...Continue Reading

Upcoming Report

$6500

Global Ocular Pain Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Ocular Pain Treatment Market report
  • The global ocular pain treatment market is expected to witness considerable growth due to increasing awareness about the eye disorders, technological advancement in ocular therapeutic and diagnostic test, and increasing number of lifestyle related ocular diseases. In addition, increasing geriatric population and increasing disposable income are further supporting the growth of the global ocular pain market. ...Continue Reading

Upcoming Report

$6500

Global Personalized Medicine Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Personalized Medicine Market report
  • The global personalized medicine market is expected to witness significant growth due rapid advancement in diagnostic techniques, population heterogeneity across the globe, increasing awareness about the benefits of genetic makeup based drugs, and improving quality of disease diagnosis. The key vendors in the global personalized medicine market are focusing on oncology, infectious disease and cardiovascular targeted treatment and diagnostics. ...Continue Reading

Upcoming Report

$6500

Global Chronic Pain Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Chronic Pain Treatment Market report
  • The global chronic pain treatment market is expected to witness considerable growth due to current unmet medical need of chronic pain, technological advancement in pain therapeutic and diagnostic test, and increasing number of chronic diseases such as cancer, arthritis, and diabetes mellitus. In addition, increasing geriatric population and increasing disposable income are supporting the growth of the global chronic pain market. The pharmaceutical ...Continue Reading

Upcoming Report

$6500

Global Endometrial Cancer Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Endometrial Cancer Treatment Market report
  • The global endometrial cancer treatment market is expected to witness growth due to unmet need of treatment, technological advancement in cancer therapeutics and diagnostic test, rising prevalence of cancer, and sedentary lifestyle of women. In addition, increasing awareness about the uterine ...Continue Reading

Upcoming Report

$6500

Global Immune Checkpoint Inhibitors Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Immune Checkpoint Inhibitors Market report
  • The global immune checkpoint inhibitors market is expected to witness significant growth as these are proven to be more effective therapy in shrinking tumor in higher proportion of patients, as compared to other immunotherapies. Immune checkpoint inhibitors are applicable to a wider range of tumor types such as advanced or metastatic non-small cell lung cancer, renal cancer and melanoma. These inhibitors lower the rate of severe toxicities ...Continue Reading

Upcoming Report

$6500

Global Human Microbiome Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research Human Microbiome Market report
  • The global human microbiome market is expected to witness significant growth due to increasing awareness towards healthy lifestyle, increasing demand for safe and effective medication, high number of patients with gastrointestinal diseases, inflammatory bowel diseases, obesity and cancer. The regulatory bodies are supporting the growth of market by providing designations and grants for speeding up the drug development process. Orphan drug designation and breakthrough therapy designation was given to RBX2660, a Rebiotix In ...Continue Reading

Upcoming Report

$6500

Global Graft Versus Host Disease (GVHD) Treatment Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research GVHD Treatment Market report
  • The global graft versus host disease (GVHD) treatment market is expected to witness considerable growth due to increasing number of hematopoietic stem cell transplantations (HSCTs), advancement in technologies, and increasing collaboration among the pharmaceutical companies. The regulatory bodies are supporting the graft versus host disease market by providing designations and grants for speeding up the drug development process. ...Continue Reading

Upcoming Report

$6500

Global Mammalian Target of Rapamycin (mTOR) Inhibitors Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research mTOR Inhibitors Market report
  • The global mammalian target of rapamycin (mTOR) inhibitors market is witnessing considerable growth due to their application in several therapeutic areas such as cancer, renal dysfunction and eye disorders. The regulatory bodies are providing funding and designation to the drug candidates for advancement of their products. Moreover, the increasing awareness related to the effective use of mTOR inhibitors, in combination with chemotherapy and its implications  ...Continue Reading

Upcoming Report

$6500

Global Natural Killer (NK) Cell Therapeutics Market - Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2022

  • P&S Market Research NK Cell Therapeutics Market report
  • The global natural killer (NK) cell therapeutics market is expected to witness considerable growth due to increasing awareness regarding immunotherapy, advancement in technologies, high demand for safe and effective medication, reduction of side effects, high prevalence of chronic diseases such as cancer and cardiovascular diseases, and increasing incidences of infectious diseases. The regulatory bodies are supporting the growth of the global market ...Continue Reading

Upcoming Report

$6500

Global Osteoporosis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulators, Rank Ligand Inhibitor, Calcitonin and Others)

  • P&S Market Research Osteoporosis Drugs Market report
  • The global osteoporosis drugs market was worth $8,835.4 million in 2015 and it is expected to grow at a CAGR of 3.8% during 2016-2022. Among the various drug classes, the rank ligand inhibitors segment is expected to witness the fastest growth, a CAGR of 4.3% during the forecast period. ...Continue Reading

November 2016

$5100

Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Type (Dry AMD, and Wet AMD), by Drug (Lucentis, Eylea, Visudyne, Avastin and Others)

  • P&S Market Research Age Related Macular Degeneration Market report
  • The global age-related macular degeneration market accounted for revenue of $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 - 2022. Among the various types, the wet AMD segment is expected to witness the faster growth during the forecast period. The global age-related macular degeneration market is growing at a significant rate, due to growing geriatric population, and increasing prevalence of age-related macular  ...Continue Reading

March 2016

$4000

Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Facial Aesthetic Relaxant Drug (Botox, Dysport, and Others), By Skeletal Muscle Relaxant Drug (Baclofen, Methocarbamol, Carisoprodol, Metaxalone, Tizanidine, and Others), and by Neuromuscular Blocking Agent (Non-depolarizing Agents, and Depolarizing Agents)

  • P&S Market Research Muscle Relaxant Drugs Market report
  • The global market of muscle relaxants is growing due to increase in geriatric population, increasing prevalence of skin diseases and harmful effects of ultra violet radiation. Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered,  ...Continue Reading

January 2016

$4500

Global Industry Insight: Pain Management Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Pain Management Drugs Market report
  • The growing geriatric population and increasing demand of innovative and advanced pain relaxing medications around the world are the predominant growth drivers for the global pain management drugs market. Additionally, the increasing number of hospitalization cases; unmet requirements for neuropathic pain management drugs; innovative and advanced applications of  ...Continue Reading

Upcoming Report

$5100

Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Hepatitis A, Hepatitis B, Hepatitis C, and Others), by Hepatitis B Drugs (Baraclude, Viread, Tyzeka, Hepsera, and Others), and By Hepatitis C Drugs (Sovaldi, OLYSIO, Harvoni, Pegasys, PegIntron, Victrelis, and Others)

  • P&S Market Research Hepatitis Drugs Market report
  • The global market of hepatitis drugs is up surging with a significant rate, due to increasing incidences of hepatitis, and increasing support from government organizations. Hepatitis is one of the leading causes of death around the world. According to the Hepatitis B Foundation, every year around 1 million deaths are recorded due to hepatitis B and its complications around the  ...Continue Reading

December 2015

$3500

Global Industry Insight: Dermatology Drug Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Dermatology Drug Market report
  • The increasing prevalence of skin diseases and growing aging population around the world are the predominant growth drivers for the global dermatology drug market. Acne, psoriasis, and dermatitis are some common skin diseases. Acne is the most common dermatological condition, which is caused by clogging of hair follicles by sebum, dirt, and dead skin cells. Acne affects  ...Continue Reading

Upcoming Report

$5100

Global Biopharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Type (Monoclonal Antibodies, Recombinant Proteins, Interferon, Colony-Stimulating Factor, Erythropoietin, Recombinant Human Insulin, Vaccines, Growth Hormones, Purified Proteins and others) and by Application (Oncology, Inflammatory and Infectious Diseases, Metabolic Disorders, Neurological Disorders, Cardiovascular Diseases and Others)

  • P&S Market Research Biopharmaceuticals Market report
  • The global biopharmaceuticals market accounted for $ 160,440.4 million in 2014, and it is expected to grow with a CAGR of 9.6% during 2015-2020. The monoclonal antibodies market segment dominated the global biopharmaceuticals market in 2014 with about 25.8% share; whereas, among application segment, the oncology segment accounted for the highest share of 27% in the  ...Continue Reading

October 2015

$5100

Global Industry Insight: Anti-Obesity Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Anti Obesity Drugs Market report
  • The global anti-obesity drugs market is growing significantly, due to high prevalence of obesity and rich pipeline for anti-obesity drugs. The presence of large patient pool and massive unexplored market in the emerging economies, such as India and China, are creating ample opportunities for the growth of the global anti-obesity drugs market. The advanced research and development ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Autoimmune Treatment Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Autoimmune Treatment Market report
  • The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Contraceptives Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Contraceptives Market report
  • The global contraceptives market is growing significantly due to increasing incidences of unwanted pregnancies, increasing prevalence of sexually transmitted diseases and advances in contraception techniques. In addition, government and non-government organizations are funding and supporting programs to encourage contraception. Large unexplored contraceptives  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Influenza Vaccine Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Influenza Vaccine Market report
  • The global influenza vaccine market is growing significantly due increasing awareness about the pandemic influenza viruses and increasing government involvement for vaccination against influenza viruses.Massive unexplored influenza vaccine marketin the emerging economiesare creating ample opportunities for the global influenza vaccine marketto grow at a significant  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Nuclear Medicine (Radiopharmaceuticals) Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Nuclear Medicine Market report
  • The global nuclear medicine/radiopharmaceuticals market is growing significantly due to increasing prevalence of cancer and cardiovascular diseases, and advances in nuclear medicine imaging procedures. High demand of nuclear medicines in emerging economies and potential radiopharmaceuticals in the pipeline create ample opportunities for the nuclear  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Active Pharmaceutical Ingredients Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Active Pharmaceutical Ingredients Market report
  • The global active pharmaceutical ingredient market is growing significantly due to patent expiry of biologic drugs in the industry. Patent expiry of blockbuster drugs has boosted the demand for low cost substitutes, which further increases the demand for active pharmaceutical ingredients in the industry. Moreover, increasing investment into biosimilars is expected to support the  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Diabetic Nephropathy Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Diabetic Nephropathy Market report
  • The increase in research and development funds for drug discovery followed by growing awareness of kidney-related disorders, and diabetes are the major factors driving the expansion of the global diabetic nephropathy market. Globally, many programs are organized by the American Diabetes Association to prevent diabetes, create awareness among vulnerable populations, and  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Uveitis Treatment Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Uveitis Treatment Market report
  • Globally, North America is the largest, while Asia-Pacific is the fastest growing uveitis treatment market. The uveitis treatment market is witnessing significant growth, due to increasing prevalence of uveitis and related complications. The global uveitis treatment market currently has many technologically innovative products in the pipeline, which are expected to improve efficiency  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Restless Legs Syndrome Market Development and Demand Forecast to 2020

  • P&S Market Research Restless Legs Syndrome Market report
  • Restless legs syndrome increases at night when the patient is at rest. RLS are common in both, male and female; however the disease has its highest impact on woman who are elderly or in some cases woman with the age 35 to 50 years. Some of the most common symptoms of the restless legs syndrome are continue itching and pain in the legs, and unusual sleep pattern. The restless legs syndrome ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Pompe Disease Market Development and Demand Forecast to 2020

  • P&S Market Research Pompe Disease Market report
  • Pompe disease is a type of lysergic acid diethylamide (LSD). LSD refers to a group of diseases arising from the increase of specific substrates and is inherited autosomal recessive disorders. Lysergic acid diethylamide is progressive and having uneven age of onset and clinical symptoms. Pompe disease is a hereditary and repeatedly incurable disorder caused by lack of acid  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Gastrointestinal Over the Counter (OTC) Drugs Market Development and Demand Forecast to 2020

  • P&S Market Research Gastrointestinal OTC Drugs Market report
  • Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are available without any prescription from the doctor. Over the counter drugs are chosen by regulatory agencies very carefully so as to ensure their efficacy and safety. ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Opioid-Induced Constipation Market Development and Demand Forecast to 2020

  • P&S Market Research Opioid Induced Constipation Market report
  • Opioids are directed to the patients suffering from the acute and chronic non-cancer pain. The opioids have numerous adverse intestinal effects, such as opioid-induced constipation. The opioids also affect the discharge of digestive enzymes that can sometime cause partial gastro paresis. Some of the most familiar symptoms of opioid-induced constipation includes, hard and dry  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Diabetic Retinopathy Market Development and Demand Forecast to 2020

  • P&S Market Research Diabetic Retinopathy Market report
  • Diabetic retinopathy refers to an eye disorder that damages or harms the blood vessels of the retina. Diabetic retinopathy can cause permanent blindness. Chronic diabetes is a major root of diabetic retinopathy. High glucose level in the blood can damage blood vessels in the retina. Diabetic retinopathy can also cause diabetic macular edema: a medical condition led to the leakage  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Cytomegalovirus Retinitis Market Development and Demand Forecast to 2020

  • P&S Market Research Cytomegalovirus Retinitis Market report
  • One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis. Innovation of products focusing on better efficacy, growing demographics and growing economies in the developing countries, such as China and India, are some of the opportunities for global cytomegalovirus retinitis market.   ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Human Insulin Market Development and Demand Forecast to 2020

  • P&S Market Research Human Insulin Market report
  • Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of  ...Continue Reading

June 2015

$5100

Global Industry Insight: Breast Cancer Market Development and Demand Forecast to 2020

  • P&S Market Research  Breast Cancer Market report
  • Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women, however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Glaucoma Therapeutics Market Development and Demand Forecast to 2020

  • P&S Market Research Glaucoma Therapeutics Market report
  • Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not treated properly, it may lead to mild loss of vision and even blindness. Treatment of glaucoma includes laser therapies, pharmaceutical drugs and surgical  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Asthma Market Development and Demand Forecast to 2020

  • P&S Market Research Asthma Market report
  • Asthma is a respiratory condition, where the airways become inflamed and narrow, which can cause a serious and incurable condition if left untreated. Breathlessness, wheezing and coughing are some of the symptoms of asthma and it can be controlled by avoiding triggers and with the help of drug therapy. Environmental triggers may vary from consumer to consumer but it can  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Choroidal Neovascularization (CNV) Market Development and Demand Forecast to 2020

  • P&S Market Research Choroidal Neovascularization Market report
  • Choroidal neovascular are the new blood vessels that grow just below the retina and interrupt the vision. Choroid, which is responsible for oxygen and nutrients supply to the eye, is the area between the retina and the sclera, where the blood vessels grow and cause choroidal neovascularization (CNV). Choroidal neovascularization break the barrier between retina and choroid  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Infectious Disease Treatment Market Development and Demand Forecast to 2020

  • P&S Market Research Infectious Disease Treatment report
  • Infectious diseases are medical conditions or disorders caused by microorganisms such as bacteria, fungi, viruses and other parasites. Several organisms are present in and on human bodies. Some organisms are normally harmless and even helpful. However, under certain circumstances, some organisms cause diseases. Infectious diseases spread from one person to another.  ...Continue Reading

Upcoming Report

$5100

Global Industry Insight: Human Growth Hormone Market Size, Share, Development, Growth and Demand Forecast to 2020

  • P&S Market Research Human Growth Hormone Market report
  • The global human growth hormone market is witnessing growth due to the presence of large pool of patients and technological advancements. The increasing compliance for human growth hormone drugs and massive unexplored market in the emerging economies, such as India and China are creating opportunities for the growth of the global human growth hormone market. The  ...Continue Reading

Upcoming Report

$5100

Let us know your requirements

Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Address : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment